Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy
Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy : a Randomized Clinical Trial
University of Sao Paulo General Hospital
60 participants
Nov 10, 2024
INTERVENTIONAL
Conditions
Summary
Assess quality of life of patients using prolonged oxygen therapy
Eligibility
Inclusion Criteria6
- Patients with a clinical, radiological and/or anatomopathological diagnosis of COPD and ILD according to the 2020 ATS/JRS/ALAT guidelines;
- Age over 18 years;
- Clinical stability (absence of exacerbations or hospitalizations related to the underlying disease) for at least 6 weeks;
- Patients who are on optimized drug therapy, including long-term home oxygen therapy (LTOT)
- Have a smartphone compatible with the monitoring device;
- Signing of the ICF to participate in the study.
Exclusion Criteria4
- Presence of other concomitant lung diseases;
- Myocardial infarction within four months prior to the start of the study, unstable angina or severe heart disease (NYHA functional class III-IV) and/or decompensated.
- Patients who received a lung transplant during the study
- Living outside the coverage area or moving out of state
Interventions
In the intervention group (IG), participants receive a HR and SPO2 monitor watch and a pulse oximeter and will be monitored every 15 days by a nurse to check for non-adherence and/or technical failure, and/or exacerbations, and monthly to apply questionnaires.
In the control group (CG), participants receive only a pulse oximeter and will be monitored monthly by a nurse to administer the questionnaires.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06882265